Cord Blood Infusion for Ischemic Stroke

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 23, 2017

Study Completion Date

February 23, 2017

Conditions
Stroke
Interventions
BIOLOGICAL

allogeneic umbilical cord blood

Umbilical cord blood units will be selected from a public cord blood bank based on ABO/Rh blood type and cell dose, targeting a range of 0.5 to 5 x 10\^7 total nucleated cells per kilogram. The cord blood unit will be intravenously infused into the subject over 5-30 minutes at a rate not exceeding 5 mL/kg/hr. Subjects will not receive immunosuppressive medications or any other cytoreduction prior to infusion.

Trial Locations (2)

27710

Duke University Medical Center, Durham

77030

Houston Methodist, Houston

All Listed Sponsors
lead

Joanne Kurtzberg, MD

OTHER

NCT02397018 - Cord Blood Infusion for Ischemic Stroke | Biotech Hunter | Biotech Hunter